MedPath

The PASSWORD Study – Promoting Safe Walking

Not Applicable
Completed
Conditions
Sedentary lifestyle, risk of mobility disability and falls, aging
Signs and Symptoms
Registration Number
ISRCTN52388040
Lead Sponsor
niversity of Jyväskylä
Brief Summary

2018 Protocol article in https://www.ncbi.nlm.nih.gov/pubmed/30219032 protocol (added 11/07/2019) 2021 Results article in https://pubmed.ncbi.nlm.nih.gov/33772877/ (added 29/03/2021) 2021 Results article in https://pubmed.ncbi.nlm.nih.gov/34644357/ (added 14/10/2021) 2020 Other publications in https://doi.org/10.1186/s12877-020-01669-7 Accelerometer-measured and self-reported physical activity in relation to extraversion and neuroticism: a cross-sectional analysis of two studies. (added 21/02/2023) 2022 Other publications in https://doi.org/10.3389/fnagi.2022.1038673 Participant characteristics associated with the effects of a physical and cognitive training program on executive functions (added 21/02/2023) 2021 Results article in https://doi.org/10.1093/gerona/glab375 Effects of Physical and Cognitive Training on Falls and Concern About Falling in Older Adults: Results From a Randomized Controlled Trial (added 21/02/2023) 2020 Results article in https://doi.org/10.1186/s11556-020-00251-9 Personality traits and physical functioning: a cross-sectional multimethod facet-level analysis (added 21/02/2023) 2023 Other publications in https://pubmed.ncbi.nlm.nih.gov/37913888/ Changes in femoral neck bone mineral density and structural strength (added 02/11/2023)

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
314
Inclusion Criteria

1. Age 70 to 85 years
2. Community-dwelling
3. Sedentary lifestyle (modified 08/11/2017: sedentary or at most moderately physically active lifestyle)
4. Ability to walk 500 m without assistance (cane is allowed)
5. Willingness to participate
6. MMSE=>24

Exclusion Criteria

1. Unable or unwilling to give informed consent or accept randomization in either study group
2. Current consumption of more than 7 (women) or 14 (men) portions of alcohol per week
3. Another member of the household is a participant in the PASSWORD -study
4. Medical, psychiatric, or behavioral factors that in the judgment of the Principal Investigator may interfere with study participation or the ability to follow the intervention protocol
5. Underlying Diseases Likely to Limit Lifespan and/or Affect the Safety of the Interventions
6. Cognitive impairment (abnormal CERAD score) or disease affecting cognition (e.g. Altzheimers disease, MCI, dementia)
7. Severe arthritis (either osteoarthritis or rheumatoid arthritis)
8. Cancer requiring treatment in the past year, except for basalioma or cancers that have clearly been cured or in the opinion of the investigator carry an excellent prognosis (e.g., Stage 1 cervical cancer)
9. Lung disease requiring either regular use of corticosteroid pills or injections or the use of supplemental oxygen
10. Cardiovascular disease (including New York Heart Association Class III or IV congestive heart failure, clinically significant aortic stenosis, history or cardiac arrest, uncontrolled angina)
11. Severe parkinson's disease or other serious neurological disorder
12. Renal disease requiring dialysis
13. Type I or II diabetes with insulin medication
14. Epilepsy with regular medication and seizures during the last year
15. Stroke or cerebral haemorrhage with complications (e.g. hemiplegia)
16. Severe musculoskeletal pain; osteoporosis with fragility fracture history
17. Psychotic disorders (e.g. schizophrenia, bipolar disorder, severe depression)
18. Difficulty in communication with study personnel due to vision or hearing problems

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
10-m maximal walking speed is measured by photocells at baseline, 6 and 12 months.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath